Effect of nivolumab (NIVO) in combination with ipilimumab (IPI) versus IPI alone on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase II study (CheckMate 069) Meeting Abstract
| Authors: | Abernethy, A. P.; Postow, M. A.; Chesney, J. A.; Grossmann, K. F.; Taylor, F.; Coon, C.; Gilloteau, I.; Dastani, H.; Gagnier, P.; Robert, C. |
| Abstract Title: | Effect of nivolumab (NIVO) in combination with ipilimumab (IPI) versus IPI alone on quality of life (QoL) in patients (pts) with treatment-naïve advanced melanoma (MEL): Results of a phase II study (CheckMate 069) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901939 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.9029 |
| Notes: | Meeting Abstract: 9029 -- Source: Wos |
